• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Amazon.com Inc.

    5/12/25 11:44:43 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $AMZN alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001659719
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    AMAZON COM INC
    SEC File Number
    000-22513
    Address of Issuer
    410 TERRY AVENUE NORTH
    SEATTLE
    WASHINGTON
    98109
    Phone
    2062661000
    Name of Person for Whose Account the Securities are To Be Sold
    Alexander Keith Brian
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    COMMON
    RBC CAPITAL MARKETS LLC
    250 NICOLLET MALL, SUITE 1700
    MINNEAPOLIS � MN � 55401
    1000210680.001061635240705/12/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    COMMON11/20/2023RSU VESTISSUERCheckbox not checked100011/20/2023N/A

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    SOLD PURSUANT TO A RULE 10B5-1 PLAN ESTABLISHED 02/10/2025
    Date of Notice
    05/12/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    02/10/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    POA / JEFFREY EISCHENS

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $AMZN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMZN

    DatePrice TargetRatingAnalyst
    4/23/2025$275.00 → $235.00Outperform
    Telsey Advisory Group
    4/22/2025$250.00 → $240.00Buy
    Jefferies
    4/21/2025$195.00Strong Buy → Outperform
    Raymond James
    4/16/2025$270.00 → $230.00Overweight
    Cantor Fitzgerald
    4/14/2025$273.00 → $225.00Buy
    Citigroup
    4/14/2025$287.00 → $206.00Buy
    Deutsche Bank
    4/14/2025$285.00 → $240.00Mkt Outperform
    Citizens JMP
    4/14/2025$280.00 → $245.00Overweight
    Morgan Stanley
    More analyst ratings

    $AMZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive Chair Bezos Jeffrey P gifted 24,410 shares, decreasing direct ownership by 0.00% to 908,779,901 units (SEC Form 4)

      4 - AMAZON COM INC (0001018724) (Issuer)

      6/5/25 4:32:18 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • CEO Worldwide Amazon Stores Herrington Douglas J sold $512,450 worth of shares (2,500 units at $204.98), decreasing direct ownership by 0.48% to 517,050 units (SEC Form 4)

      4 - AMAZON COM INC (0001018724) (Issuer)

      6/4/25 5:10:07 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • CEO Worldwide Amazon Stores Herrington Douglas J converted options into 17,107 shares and sold $1,373,851 worth of shares (6,843 units at $200.77), increasing direct ownership by 2% to 519,550 units (SEC Form 4)

      4 - AMAZON COM INC (0001018724) (Issuer)

      5/23/25 6:40:08 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    SEC Filings

    See more
    • SEC Form SD filed by Amazon.com Inc.

      SD - AMAZON COM INC (0001018724) (Filer)

      5/30/25 4:06:48 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amazon.com Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - AMAZON COM INC (0001018724) (Filer)

      5/22/25 4:31:45 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form 144 filed by Amazon.com Inc.

      144 - AMAZON COM INC (0001018724) (Subject)

      5/15/25 4:29:41 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • March 11, 2025 - FDA Roundup: March 11, 2025

      For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

      3/13/25 3:14:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • November 14, 2023 - FDA Roundup: November 14, 2023

      For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

      11/14/23 3:26:18 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Double the Days, Millions of Deals: Amazon Announces Prime Day Event from July 8 to July 11, Offering Members More Time to Shop and Save

      Shop some of Amazon's best deals of the season including deals across more than 35 categories from fashion and beauty to groceries, household essentials, and electronics; Amazon's lowest prices of the year so far from top brands like Sony, Dyson, and Living Proof; and deals from exciting new-to-Amazon brands like Unwell Hydration, Tarte Cosmetics, and Away. Early deals start now across top categories including BBQ essentials starting at $3, grocery and household essentials under $5, and swimwear from $12; Plus, customers with Early Access to Alexa+ can ask Alexa to let them know when an item they want goes on sale for Prime Day. Get ahead on school shopping with school tech must-haves s

      6/17/25 1:00:00 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • New Findings from NSC Grant Recipients Help Tackle America's Most Common Workplace Injury

      MSD Solutions Lab programs unite academic researchers and industry partners to drive innovation WASHINGTON, June 11, 2025 /PRNewswire/ -- The National Safety Council released findings from 2023-2024 MSD Solutions Lab Research to Solutions (R2S) and MSD Solutions Pilot Grant programs. Results showed practical applications and measurable progress toward reducing musculoskeletal disorders (MSDs), the most common workplace injury. Launched by the MSD Solutions Lab, a groundbreaking NSC initiative established in 2021 with funding from Amazon (NASDAQ:AMZN), the grant programs empowe

      6/11/25 3:00:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Smart Healthcare Is Taking Over. Here's Where the Money's Headed

      Issued on behalf of Avant Technologies Inc.Equity Insider News Commentary VANCOUVER, BC, June 10, 2025 /PRNewswire/ -- Both politicians and leaders in academia are touting the AI revolution empowering the frontline of what's dubbed Smart Healthcare. In a recent write-up in Forbes, Prof. Nicos Savva of the London Business School cited recent speeches from former British Prime Minister Tony Blair, who insists that the UK needs to embrace a future with AI doctors and nurses, or risk being left behind. A new report from Wolters Kluwer has experts calling for more clarity around its use, adoption, and business strategy, because most healthcare organizations aren't currently ready to use GenAI too

      6/10/25 11:13:00 AM ET
      $AMZN
      $GOOG
      $GOOGL
      $OMDA
      Catalog/Specialty Distribution
      Consumer Discretionary
      Computer Software: Programming Data Processing
      Technology